HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan L Curry Selected Research

Keratosis

9/2019Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response.
3/2014Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions.
2/2013Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan L Curry Research Topics

Disease

45Neoplasms (Cancer)
09/2022 - 02/2009
32Melanoma (Melanoma, Malignant)
10/2022 - 01/2012
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 08/2012
10Carcinoma (Carcinomatosis)
09/2022 - 10/2011
6Bullous Pemphigoid (Pemphigoid)
07/2021 - 08/2016
6Dermatitis
06/2021 - 02/2017
6Neoplasm Metastasis (Metastasis)
10/2020 - 08/2012
6Mycosis Fungoides
11/2019 - 03/2011
5Keratoacanthoma
07/2015 - 02/2013
4Merkel Cell Carcinoma
09/2022 - 11/2014
4Lymphoma (Lymphomas)
01/2022 - 04/2015
4Nevus (Nevi)
10/2020 - 08/2007
3Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 08/2016
3Sarcoma (Soft Tissue Sarcoma)
04/2021 - 11/2013
3Keratosis
09/2019 - 02/2013
2B-Cell Lymphoma (Lymphoma, B Cell)
04/2022 - 05/2021
2Leukemia
04/2022 - 01/2022
2Pemphigus (Pemphigus Vulgaris)
04/2021 - 10/2018
2Hypersensitivity (Allergy)
01/2021 - 03/2014
2Pigmented Nevus (Melanocytic Nevus)
09/2019 - 08/2007
2Blister (Bulla)
07/2018 - 08/2016
2Panniculitis
12/2017 - 08/2015
2Exanthema (Rash)
12/2017 - 03/2014
2Grover's disease
01/2017 - 01/2016
2Warts (Wart)
07/2014 - 03/2014
2Actinic Keratosis
07/2014 - 03/2014
2Skin Diseases (Skin Disease)
03/2014 - 12/2012
1Residual Neoplasm
09/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022
1Adenocarcinoma
05/2022
1Acrodermatitis enteropathica
05/2022
1Exfoliative Dermatitis (Erythroderma)
05/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2022
1Tertiary Lymphoid Structures
05/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2021
1Chondrosarcoma
05/2020
1Hyperpigmentation
05/2020
1Lichen Planus (Lichen Ruber Planus)
05/2020

Drug/Important Bio-Agent (IBA)

11Immune Checkpoint InhibitorsIBA
05/2022 - 01/2017
9Biomarkers (Surrogate Marker)IBA
11/2020 - 08/2012
7Proteins (Proteins, Gene)FDA Link
07/2021 - 02/2009
7VemurafenibIBA
03/2016 - 12/2012
6pembrolizumabIBA
04/2021 - 08/2016
5LigandsIBA
01/2022 - 02/2017
4Monoclonal AntibodiesIBA
05/2021 - 12/2015
4Biological ProductsIBA
05/2020 - 01/2015
4dabrafenibIBA
09/2019 - 02/2013
4CTLA-4 AntigenIBA
07/2018 - 01/2017
3NivolumabIBA
05/2022 - 08/2016
3Formaldehyde (Formol)FDA Link
11/2019 - 12/2012
3IpilimumabIBA
08/2017 - 01/2016
3Sorafenib (BAY 43-9006)FDA Link
07/2015 - 01/2014
2SteroidsIBA
05/2022 - 02/2015
2Azacitidine (5 Azacytidine)FDA Link
01/2022 - 12/2017
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 03/2014
2Transforming Growth Factor beta (TGF-beta)IBA
07/2021 - 05/2020
2RNA (Ribonucleic Acid)IBA
04/2021 - 01/2019
2Cyclin D1IBA
04/2021 - 04/2016
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2020 - 02/2017
2Pharmaceutical PreparationsIBA
12/2019 - 01/2014
2ParaffinIBA
11/2019 - 12/2012
2Anti-Bacterial Agents (Antibiotics)IBA
10/2019 - 03/2018
2Paclitaxel (Taxol)FDA LinkGeneric
06/2018 - 03/2016
2Melanins (Melanin)IBA
08/2017 - 06/2014
2Indicators and Reagents (Reagents)IBA
11/2016 - 01/2012
2MicroRNAs (MicroRNA)IBA
01/2016 - 10/2015
2Histones (Histone)IBA
11/2014 - 01/2012
2Carcinoembryonic AntigenIBA
06/2014 - 06/2012
1AntigensIBA
10/2022
1Amyloid (Amyloid Fibrils)IBA
09/2022
1Coloring Agents (Dyes)IBA
09/2022
1Congo RedIBA
09/2022
1ZincIBA
05/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
04/2022
1ibrutinibIBA
04/2022
1Mitogen-Activated Protein KinasesIBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1PLX51107IBA
01/2022
1cemiplimabIBA
05/2021
1S100 Proteins (S 100 Protein)IBA
04/2021
1olaparibIBA
01/2021
1palbociclibIBA
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
1enfortumab vedotinIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1PlatinumIBA
01/2021
1abemaciclibIBA
01/2021
1Karyopherins (Importin)IBA
10/2020
1CateninsIBA
10/2020
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
05/2020
1Metronidazole (Metric)FDA LinkGeneric
05/2020

Therapy/Procedure

46Therapeutics
09/2022 - 03/2011
10Immunotherapy
09/2022 - 01/2016
5Drug Therapy (Chemotherapy)
09/2022 - 12/2012
4Aftercare (After-Treatment)
07/2018 - 02/2013
2Neoadjuvant Therapy
05/2021 - 07/2018
2Radiotherapy
01/2016 - 08/2015
1Castration
01/2021